arrow
C

Cláudio N. Soares

queens university
H指数:54
被引数:9,194

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring sex differences in endocannabinoid system biomarkers and their relationship with antidepressant treatment outcomes in major depressive disorder: a CAN-BIND 1 secondary analysis

探索内源性大麻素系统生物标志物的性别差异及其与重度抑郁症抗抑郁治疗效果的关系:一项CAN-BIND 1次级分析

2026-08-250
PRE
Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program

恩利沙奈坦特对不同人群中与绝经相关的血管舒缩症状和睡眠障碍的疗效和安全性的一致性:OASIS临床研究项目综述

2026-07-250
OAAI
Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l’étude CAN-BIND-1

抑郁症治疗期间大脑时序复杂性的调节:CAN-BIND-1研究报告:抑郁症治疗期间大脑时序复杂性的调节:CAN-BIND-1研究报告

2025-12-260
PRE
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview

加拿大致幻剂辅助癌症疗法网络(CAN-PACT):一项多阶段项目概述

2025-12-220
OAAI
The burden of sleep disturbances and vasomotor symptoms on work productivity, activity impairment and healthcare resource use in perimenopausal and postmenopausal women

睡眠障碍和血管舒缩症状对围绝经期和绝经后女性工作生产力、活动能力损害及医疗资源利用的负担

2025-11-010
PRE
Socioeconomic status is associated with reward processing, interleukin 1β, striatal connectivity and antidepressant outcomes in individuals with major depressive disorder: A CAN-BIND-1 report.

社会经济地位与奖励处理、白细胞介素1β、纹状体连接以及抗抑郁治疗效果在重度抑郁症个体中相关:一项CAN-BIND-1研究报告。

2025-10-310
OAAI
Perceptions and insights: A qualitative assessment of an AI-assisted psychiatric triage system implemented in an outpatient hospital setting

感知与洞察:一项关于在门诊医院环境中实施的AI辅助精神科分诊系统的定性评估

2025-10-150
OA
Standardized EEG for multi-site biomarker-informed trials: implementation in the Canadian biomarker integration network in depression

多中心生物标志物指导试验中的标准化EEG:在加拿大抑郁症生物标志物整合网络中的应用

2025-07-110
OAAI
Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1 (vol 16, e0253023, 2021)

机器学习方法的复制,用于预测重度抑郁症患者使用抗抑郁药物的治疗结局,数据来源于STAR*D和CAN-BIND-1 (vol 16, e0253023, 2021)

2024-12-120
OA
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study
2024-10-120
OAAI
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study

艾司西酞普兰和阿立哌唑治疗抑郁症的综合遗传变异,DNA甲基化和基因表达分析: 一项CAN-BIND-1研究

2024-06-250
PRE
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

加拿大情绪和焦虑治疗网络 (CANMAT) 2023成人重度抑郁症管理临床指南的更新: 加拿大研究和发展研究 (CANMAT) 2023: Mise à jour des lignes directrices cliniques to la priseen charge du adjeur chez les adultes

2024-05-0652
OAAI
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
2023-09-152
OAAI